Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Articolo
Data di Pubblicazione:
2015
Abstract:
BACKGROUND: The 5-year cancer specific survival (CSS) for patients with muscle invasive urothelial carcinoma of the bladder (MIBC) treated with cystectomy alone is approximately 50%. Platinum based neoadjuvant chemotherapy (NAC) plus cystectomy results in a marginal 5-10% increase in 5-year CSS in MIBC. Interestingly, responders to NAC (
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Baras Alexander, S; Gandhi, Nilay; Munari, E; Faraj, Sheila; Shultz, Luciana; Marchionni, Luigi; Schoenberg, Mark; Hahn, Noah; Hoque Mohammad, Obaidul; Hoque, Mohammad; Berman, David; Bivalacqua Trinity, J; Netto, George
Link alla scheda completa:
Pubblicato in: